GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Tech & Admin support
    • Scientific Advisory Board
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases
      • IHC – Individual health care
    • Research in numbers
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
  • Networks & Partnerships
  • Reports
    • GHTM
    • Scientific Advisory Board
    • FCT
Home / Publications / Sesquiterpenes effects on DNA of Schistosoma mansoni after in vivo treatment

Sesquiterpenes effects on DNA of Schistosoma mansoni after in vivo treatment

  • Authors: de Oliveira RN, Ferreira PM, Calado M, Belo S, Afonso A, Garcia VL, Oliveira ASS, de Lurdes Sierpe Jeraldo V, dos Santos KR, Allegretti SM
  • Publication Year: 2018
  • Journal: Gene Reports
  • Link: https://www.sciencedirect.com/science/article/pii/S2452014418300372?via%3Dihub

Schistosomiasis is a chronic Neglected Tropical Disease that can be debilitating, particularly children, of tropical and subtropical regions presenting an enormous global health and economic burden. Notoriously for over 30 years, the praziquantel (PZQ) is the only drug used for treatment of disease. For this reason, the search for new schistosomicidal drugs is a priority. Natural products have played and continue to play an invaluable role in the new drug discovery. In addition, the identification and characterization of molecular markers has been used for direct study of S. mansoni genome in different development stage of life-cycle. In this study, we identify light genetic polymorphisms in S. mansoni genome, using RAPD-PCR technique, after in vivo treatment with metabolites from B. trimera, essential oils (EO) and sesquiterpenes, on different stages of development: schistosomula, juvenile and adult of S. mansoni. Results showed that five, of the total of twelve evaluated primers, lead to different band patterns, with same monomorphic DNA fragments, from worms recovered after different treatment periods thus suggesting that a single dose (100 mg/kg) of essential oil (EO) and sesquiterpenes (α-HL and T-CP) does not lead to selection of parasites with large DNA genomic polymorphisms both in male or female S. mansoni worms. However, despite being preliminary, the molecular results achieved show that further analysis are required to better understand the molecular mechanisms involved. Future application of other molecular markers, in particular, the study of more conserved or specific genes are of a particular interest to verify your hypothesis.

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to print (Opens in new window)

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • E-mail
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Map

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2025 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok